EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Kinetics of the humoral and cellular immune response up to 1 year from mpox virus infection

Valentina Mazzotta, Giulia Matusali, Eleonora Cimini, Francesca Colavita, Rozenn Esvan, Stefania Notari, Giulia Micheli, Aurora Bettini, Eleonora Tartaglia, Alessandro Giacinta, Rita Casetti, Serena Vita und 9 weitere

Clinical Microbiology and Infection · 2025

DOI: 10.1016/j.cmi.2025.04.026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Microbiology and Infection, 2025. Verfasst von Valentina Mazzotta und 20 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Infectious Diseases Department, National Institute for Infectious Diseases "Lazzaro Spallanzani"-IRCCS, Rome, Italy. Hauptthemen laut MEDLINE: Immunity, Cellular, Immunity, Humoral, Mpox, Monkeypox. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministero della Salute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: The immunological signature of mpox Clade IIb was described in the early stages of infection. We aimed to characterize the kinetics of both humoral and cellular immune responses against mpox from the onset of symptoms up to one year later. METHODS: Sixty-nine patients with mpox infected with Clade IIb during the 2022 outbreak were included in a longitudinal study. Blood samples were collected during the first 3 weeks and 3-4 (T3-4M), 6-8 (T6-8M), and 12 months (T12M) after infection. Mpox-specific IgM, IgA, IgG, and neutralizing antibodies (nAbs) titres were measured by immunofluorescence assay and 50% plaque reduction neutralization test. Interferon-γ producing specific T-cells to Modified Vaccinia Ankara (MVA) peptides was assessed by ELISpot assay. CD4+ and CD8+ T-cells phenotypic markers (CD38/CD57/PD-1) were performed by flow cytometry. RESULTS: All the humoral markers were detected as early as 4 days and peaked at week 2 (IgG) or 3 (IgM, IgA, nAbs) from symptoms onset. At T3-4M from onset, the antibody levels decreased, and IgM was detected in only one patient; IgA in 50% (13/26), IgG and nAbs in 92% (24/26) of participants. Further decreases in IgG and nAb mean titres were observed at 6-8M. At T12M, IgM, IgA, IgG, and nAbs were detected in 4 (2/47), 48 (23/47), 93 (44/47) and 78% (37/47) of patients, respectively. MVA-specific T-cell response was detected early in the acute phase of infection, peaked at T3M and are maintained until T12M. DISCUSSION: These data provide evidence of persistence of humoral and cellular immune response 1 year after natural infection, suggesting the maintenance of adequate immune memory. Further study is needed to assess longer persistence of immunity and the cross-protection against different mpox clades.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunity, CellularImmunity, HumoralMpox, MonkeypoxAdultAgedFemaleHumansMaleMiddle AgedYoung AdultAntibodies, NeutralizingAntibodies, ViralDisease OutbreaksImmunoglobulin GImmunoglobulin MLongitudinal Studies

Stichwörter der Autor:innen

Cellular responseHIVHumoral responseImmune responseMpox

Substanzen

Antibodies, NeutralizingAntibodies, ViralImmunoglobulin GImmunoglobulin M

Autor:innen und Institutionen

  • Clinical Infectious Diseases Department, National Institute for Infectious Diseases "Lazzaro Spallanzani"-IRCCS, Rome, Italy.
  • Laboratory of Virology, National Institute for Infectious Diseases "Lazzaro Spallanzani"-IRCCS, Rome, Italy.
  • Laboratory of Cellular Immunology and Pharmacology, National Institute for Infectious Diseases "Lazzaro Spallanzani"-IRCCS, Rome, Italy. Electronic address: eleonora.cimini@inmi.it.
  • Laboratory of Cellular Immunology and Pharmacology, National Institute for Infectious Diseases "Lazzaro Spallanzani"-IRCCS, Rome, Italy.
  • Laboratory of Microbiology and Biological Bank Unit, National Institute for Infectious Diseases "Lazzaro Spallanzani"-IRCCS, Rome, Italy.
  • Scientific Direction, National Institute for Infectious Diseases "Lazzaro Spallanzani"-IRCCS, Rome, Italy.

Förderung

  • Ministero della Salute

Zitieren

APA

Mazzotta, V., Matusali, G., Cimini, E., Colavita, F., Esvan, R., Notari, S., Micheli, G., Bettini, A., Tartaglia, E., Giacinta, A., Casetti, R., Vita, S., Grassi, G., Mariotti, D., Oliva, A., Paulicelli, J., Prota, G., Girardi, E., Nicastri, E., …, & Antinori, A. (2025). Kinetics of the humoral and cellular immune response up to 1 year from mpox virus infection. Clinical Microbiology and Infection. https://doi.org/10.1016/j.cmi.2025.04.026

Vancouver

Mazzotta V, Matusali G, Cimini E, Colavita F, Esvan R, Notari S, et al. Kinetics of the humoral and cellular immune response up to 1 year from mpox virus infection. Clinical Microbiology and Infection. 2025. doi:10.1016/j.cmi.2025.04.026

BibTeX
@article{Mazzotta2025,
  author = {Mazzotta, Valentina and Matusali, Giulia and Cimini, Eleonora and Colavita, Francesca and Esvan, Rozenn and Notari, Stefania and Micheli, Giulia and Bettini, Aurora and Tartaglia, Eleonora and Giacinta, Alessandro and Casetti, Rita and Vita, Serena and Grassi, Germana and Mariotti, Davide and Oliva, Alessandra and Paulicelli, Jessica and Prota, Gianluca and Girardi, Enrico and Nicastri, Emanuele and Maggi, Fabrizio and Antinori, Andrea},
  title = {Kinetics of the humoral and cellular immune response up to 1 year from mpox virus infection},
  journal = {Clinical Microbiology and Infection},
  year = {2025},
  doi = {10.1016/j.cmi.2025.04.026}
}
Kostenlos starten →